Ventrix’s VentriGel™ Demonstrates Potential to Prevent Heart Failure Following Heart Attack

Ventrix, Inc. announced today that its VentriGel™ cardiac repair scaffold safely and effectively mitigated left ventricular remodeling and improved cardiac function in pigs after myocardial infarction. The findings, made during pre-clinical studies, have been published in the journal Science Translational Medicine.